A MILTON Keynes clinical trial support company is on track to record a 700 per cent growth in turnover by the end of this financial year.
Medical Research Network (MRN), in Talon House, Presley Way, was set up as a management buy out from Healthcare at Home in November, 2006 with just six dedicated staff members.
In its first five years, MRN’s revenues have grown by 533 per cent and present forecasts predict a 170 per cent increase on top of that by the end of this financial year, making it a leading global provider of home healthcare for patients in clinical trials.
MRN has been involved in the conduct of projects across a wide range of therapeutic areas, ranging from trials in oncology, rheumatology, enzyme replacement therapy, hematology and others requiring drug administration of intravenous therapies and other injectables in the home, through to simple blood draws in neurology, anti infectives, respiratory and renal.
MRN’s chief executive, Dr Graham Wylie, said: “The growth of the company has been driven by our commitment to meeting the needs of customers as they explore the benefits of MRN’s services requesting we work in more and more countries with increasingly large projects.
“With MRN’s services, customers continually see improvements in recruitment and retention of patients in their trials – two of the major challenges in clinical research today. Our ability to take the trial to the patient makes participation more convenient and appealing and boosts recruitment rates by over 60 per cent even in the simplest of trials. The reduction in the impact of the trial on the patient’s life is one of the few truly patient centric classes of services available for trials today, significantly improving retention rates, which are consistently over 95 per cent in all projects we handle.”
Over the years staff numbers have risen near-fivefold to 28 full-time staff and several contract staff supporting HQ functions, as well as hundreds of nurses around the globe delivering services in four continents.